Recruiting
Phase 2

A Study to Assess the Efficacy and Safety of Daily OM-85 in Young Children with Recurrent Wheezing

Sponsor:

OM Pharma SA

Code:

NCT05857930

Conditions

Recurrent Wheezing

Wheezing Lower Respiratory Illness

Eligibility Criteria

Sex: All

Age: 6 - 70+

Healthy Volunteers: Not accepted

Interventions

OM-85

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information